Literature DB >> 25459015

Chylothorax and chylous ascites: management and pitfalls.

Juan C Lopez-Gutierrez1, Juan A Tovar2.   

Abstract

Leakage of lymph from the lymphatic ducts causes chylothorax (CT) or chylous ascitis (CA). This may happen for unknown reasons during fetal life or after birth and may also be caused by trauma after thoracic surgery or by other conditions. Fetal CT and CA may be lethal particularly in cases with fetal hydrops that sometimes benefit of intra-uterine instrumentation. After birth, symptoms are related to the amount of accumulated fluid. Sometimes, severe cardio-respiratory compromise prompts active therapy. Most patients with CT or CA benefit from observation, rest, and supportive measures alone. Drainage of the fluid may be necessary, but then loss of protein, fat, and lymphoid cells introduce new risks and require careful replacement. Low-fat diets with MCT and parenteral nutrition decrease fluid production while allowing adequate nutritional input. If lymph leakage does not stop, secretion inhibitors like somatostatin or octreotide are prescribed, although there is only weak evidence of their benefits. Imaging of the lymphatic system is indicated when the leaks persist, but this is technically demanding in children. Shunting of the lymph from one body space to another by means of valved catheters, embolization of the thoracic duct, and/or ligation of the major lymphatics may occasionally be indicated in cases refractory to all other treatments.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chyloperitoneum; Chylothorax; Chylous ascites; Fetal ascites; Fetal chylothorax; Fetal hydrops; Lymph; MCT; Parenteral nutrition; Shunt

Mesh:

Year:  2014        PMID: 25459015     DOI: 10.1053/j.sempedsurg.2014.09.011

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  7 in total

Review 1.  The thoracic duct: clinical importance, anatomic variation, imaging, and embolization.

Authors:  Oren W Johnson; Jeffrey Forris Beecham Chick; Nikunj Rashmikant Chauhan; Alexandra Holmsen Fairchild; Chieh-Min Fan; Michael S Stecker; Timothy P Killoran; Alisa Suzuki-Han
Journal:  Eur Radiol       Date:  2015-12-01       Impact factor: 5.315

2.  Congenital Chylothorax of the Newborn: A Systematic Analysis of Published Cases between 1990 and 2018.

Authors:  Bernhard Resch; Gülsen Sever Yildiz; Friedrich Reiterer
Journal:  Respiration       Date:  2021-09-01       Impact factor: 3.580

Review 3.  Chylous Ascites and Lymphoceles: Evaluation and Interventions.

Authors:  Ernesto Santos; Amgad M Moussa
Journal:  Semin Intervent Radiol       Date:  2020-07-31       Impact factor: 1.513

Review 4.  Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment.

Authors:  Richa Bhardwaj; Haleh Vaziri; Arun Gautam; Enrique Ballesteros; David Karimeddini; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2017-12-04

Review 5.  Physiological Perspective on Therapies of Lymphatic Vessels.

Authors:  Witold W Kilarski
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-07-01       Impact factor: 4.730

6.  Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders.

Authors:  Jana Pospiskova; Lukas Smolej; David Belada; Martin Simkovic; Monika Motyckova; Alice Sykorova; Pavla Stepankova; Pavel Zak
Journal:  Orphanet J Rare Dis       Date:  2019-01-09       Impact factor: 4.123

7.  Hypoplasia of abdominal wall muscles following massive fetal persistent chylous ascites without anemia.

Authors:  Tetsu Yamaguchi; Shunsuke Tamaru; Natsuko Takano; Kazuko Sato; Hayato Sakurai; Hirofumi Ohashi; Yoshimasa Kamei
Journal:  Oxf Med Case Reports       Date:  2021-06-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.